Anti‑migratory effect of rapamycin impairs allograft imaging by 18F‑fluorodeoxyglucose‑labeled splenocytes

Sun,Hukui; Cheng,Dayan; Ma,Yuanyuan; Liu,Hong; Yang,Ning; Zhang,Cong; Wang,Kai; Hou,Guihua; Wang,Huaiquan

doi:10.3892/mmr.2016.5507

Anti‑migratory effect of rapamycin impairs allograft imaging by 18F‑fluorodeoxyglucose‑labeled splenocytes

Authors:
- Hukui Sun
- Dayan Cheng
- Yuanyuan Ma
- Hong Liu
- Ning Yang
- Cong Zhang
- Kai Wang
- Guihua Hou
- Huaiquan Wang
View Affiliations

Affiliations: Nuclear Medicine Department, Central Hospital of Zibo, Shandong University, Zibo, Shandong 255036, P.R. China, Biomedical Isotope Research Center, School of Medicine, Shandong University, Jinan, Shandong 250012, P.R. China
Published online on: July 12, 2016 https://doi.org/10.3892/mmr.2016.5507
Pages: 2194-2198

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Tracking lymphocyte migration is an emerging strategy for non‑invasive nuclear imaging of allografts; however, its clinical application remains to be fully demonstrated. In the present study, the feasibility of using rapamycin‑treated 18F‑fluorodeoxyglucose (18F‑FDG)‑labeled splenocytes for the in vivo imaging of allografts was evaluated. C57BL/6 skin was heterotopically transplanted onto non‑obese diabetic/severe combined immunodeficient recipient mice. BALB/c 18F‑FDG‑labeled splenocytes with or without rapamycin pretreatment (designated as FR and FC cells, respectively) were transferred into recipient mice 30 days later. Imaging of radiolabeled cells in the skin grafts was conducted through in vivo dynamic whole‑body phosphor‑autoradiography and histological analysis. Notably, rapamycin impaired the migration of 18F‑FDG‑labeled splenocytes to the graft. At all time points, the radioactivity of allografts (digital light units/mm2) was significantly lower in the group that received FR cells, compared with the group that received FC cells (P<0.01). Furthermore, the peak allograft to native skin ratio was 1.29±0.02 at 60 min for the FR group and 3.29±0.17 at 30 min for the FC group (P<0.001). In addition, the in vivo radioactivity of the allografts was observed to be correlated with the transferred cells, which were observed histologically (r2=0.887; P<0.0001). Although 18F‑FDG‑labeled splenocytes migrated to the allograft, imaging of these cells may not be possible in the presence of rapamycin.

View Figures

View References

1	Baraldi-Junkins C, Levin HR, Kasper EK, Rayburn BK, Herskowitz A and Baughman KL: Complications of endo-myocardial biopsy in heart transplant patients. J Heart Lung Tranplant. 12:63–67. 1993.
2	Mueller TF, Reeve J, Jhangri GS, Mengel M, Jacaj Z, Cairo L, Obeidat M, Todd G, Moore R, Famulski KS, et al: The transcriptome of the implant biopsy identifies donor kidneys at increased risk of delayed graft function. Am J Transplant. 8:78–85. 2008.
3	Virostko J, Henske J, Vinet L, Lamprianou S, Dai C, Radhika A, Baldwin RM, Ansari MS, Hefti F, Skovronsky D, et al: Multimodal image coregistration and inducible selective cell ablation to evaluate imaging ligands. Proc Natl Acad Sci USA. 108:20719–20724. 2011. View Article : Google Scholar : PubMed/NCBI
4	Signore A, Mather SJ, Piaggio G, Malviya G and Dierckx RA: Molecular imaging of inflammation/infection: Nuclear medicine and optical imaging agents and methods. Chem Rev. 110:3112–3145. 2010. View Article : Google Scholar : PubMed/NCBI
5	Tsuji AB, Morita M, Li XK, Sogawa C, Sudo H, Sugyo A, Fujino M, Sugioka A, Koizumi M and Saga T: 18F-FDG PET for semiquantitative evaluation of acute allograft rejection and immunosuppressive therapy efficacy in rat models of liver transplantation. J Nucl Med. 50:827–830. 2009. View Article : Google Scholar : PubMed/NCBI
6	Reuter S, Schnöckel U, Edemir B, Schröter R, Kentrup D, Pavenstädt H, Schober O, Schlatter E, Gabriëls G and Schäfers M: Potential of noninvasive serial assessment of acute renal allograft rejection by 18F-FDG PET to monitor treatment efficiency. J Nucl Med. 51:1644–1652. 2010. View Article : Google Scholar : PubMed/NCBI
7	Grabner A, Kentrup D, Edemir B, Sirin Y, Pavenstädt H, Schlatter E, Schober O, Schäfers M, Schnöckel U and Reuter S: PET with F-18-FDG-labeled T lymphocytes for diagnosis of acute rat renal allograft rejection. J Nucl Med. 54:1147–1153. 2013. View Article : Google Scholar : PubMed/NCBI
8	Kimura T, Hasegawa T, Nakai H, Azuma T, Usui N, Sasaki T and Okada A: FTY720 reduces T-cell recruitment into murine intestinal allograft and prevents activation of graft-infiltrating cells. Transplantation. 75:1469–1474. 2003. View Article : Google Scholar : PubMed/NCBI
9	Heidt S, Roelen DL, Eijsink C, van Kooten C, Claas FH and Mulder A: Effects of immunosuppressive drugs on purified human B cells: Evidence supporting the use of MMF and rapamycin. Transplantation. 86:1292–1300. 2008. View Article : Google Scholar : PubMed/NCBI
10	Brown FG, Nikolic-Paterson DJ, Metz C, Bucala R, Atkins RC and Lan HY: Up-regulation of macrophage migration inhibitory factor in acute renal allograft rejection in the rat. Clin Exp Immunol. 118:329–336. 1999. View Article : Google Scholar : PubMed/NCBI
11	Sun H, Yang G, Liang T, Zhang C, Song J, Han J and Hou G: Non-invasive imaging of allogeneic transplanted skin graft by 131I-anti-TLR5 mAb. J Cell Mol Med. 18:2437–2444. 2014. View Article : Google Scholar : PubMed/NCBI
12	Cao W, Manicassamy S, Tang H, Kasturi SP, Pirani A, Murthy N and Pulendran B: Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI (3)K-mTOR-p70S6K pathway. Nat Immunol. 9:1157–1164. 2008. View Article : Google Scholar : PubMed/NCBI
13	Strauss L, Czystowska M, Szajnik M, Mandapathil M and Whiteside TL: Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin. PLoS One. 4:e59942009. View Article : Google Scholar : PubMed/NCBI
14	Sauer S, Bruno L, Hertweck A, Finlay D, Leleu M, Spivakov M, Knight ZA, Cobb BS, Cantrell D, O'Connor E, et al: T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc Natl Acad Sci USA. 105:7797–7802. 2008. View Article : Google Scholar : PubMed/NCBI
15	Battaglia M, Stabilini A and Roncarolo MG: Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood. 105:4743–4748. 2005. View Article : Google Scholar : PubMed/NCBI
16	Hidalgo M and Rowinsky EK: The rapamycin-sensitive signal transduction pathway as a target for cancer therapy. Oncogene. 19:6680–6686. 2000. View Article : Google Scholar
17	Wullschleger S, Loewith R and Hall MN: TOR signaling in growth and metabolism. Cell. 124:471–484. 2006. View Article : Google Scholar : PubMed/NCBI
18	Teutonico A, Schena PF and Di Paolo S: Glucose metabolism in renal transplant recipients: Effect of calcineurin inhibitor withdrawal and conversion to sirolimus. J Am Soc Nephrol. 16:3128–3135. 2005. View Article : Google Scholar : PubMed/NCBI
19	Finlay D and Cantrell D: Phosphoinositide 3-kinase and the mammalian target of rapamycin pathways control T cell migration. Ann N Y Acad Sci. 1183:149–157. 2010. View Article : Google Scholar : PubMed/NCBI
20	Hou G, Valujskikh A, Bayer J, Stavitsky AB, Metz C and Heeger PS: In vivo blockade of macrophage migration inhibitory factor prevents skin graft destruction after indirect allorecognition. Transplantation. 72:1890–1897. 2001. View Article : Google Scholar
21	Fantini MC, Dominitzki S, Rizzo A, Neurath MF and Becker C: In vitro generation of CD4+ CD25+ regulatory cells from murine naive T cells. Nat Protoc. 2:1789–1794. 2007. View Article : Google Scholar : PubMed/NCBI
22	Meier R, Piert M, Piontek G, Rudelius M, Oostendorp RA, Senekowitsch-Schmidtke R, Henning TD, Wels WS, Uherek C, Rummeny EJ and Daldrup-Link HE: Tracking of [18F] FDG-labeled natural killer cells to HER2/neu-positive tumors. Nucl Med Biol. 35:579–588. 2008. View Article : Google Scholar
23	Butler KS, Lovato DM, Adolphi NL, Belfon R, Fegan DL, Monson TC, Hathaway HJ, Huber DL, Tessier TE, Bryant HC, et al: Development of antibody-tagged nanoparticles for detection of transplant rejection using biomagnetic sensors. Cell Transplant. 22:1943–1954. 2013. View Article : Google Scholar
24	Tanaka M, Swijnenburg RJ, Gunawan F, Cao YA, Yang Y, Caffarelli AD, de Bruin JL, Contag CH and Robbins RC: In vivo visualization of cardiac allograft rejection and trafficking passenger leukocytes using bioluminescence imaging. Circulation. 112(9 Suppl): I105–I110. 2005.PubMed/NCBI
25	Greiner DL, Shultz LD, Yates J, Appel MC, Perdrizet G, Hesselton RM, Schweitzer I, Beamer WG, Shultz KL, Pelsue SC, et al: Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice. Am J Pathol. 146:888–902. 1995.PubMed/NCBI
26	Valmori D, Tosello V, Souleimanian NE, Godefroy E, Scotto L, Wang Y and Ayyoub M: Rapamycin-mediated enrichment of T cells with regulatory activity in stimulated CD4+ T cell cultures is not due to the selective expansion of naturally occurring regulatory T cells but to the induction of regulatory functions in conventional CD4+ T cells. J Immunol. 177:944–949. 2006. View Article : Google Scholar : PubMed/NCBI
27	Ishimori T, Saga T, Mamede M, Kobayashi H, Higashi T, Nakamoto Y, Sato N and Konishi J: Increased (18)F-FDG uptake in a model of inflammation: Concanavalin A-mediated lymphocyte activation. J Nucl Med. 43:658–663. 2002.PubMed/NCBI
28	Pellegrino D, Bonab AA, Dragotakes SC, Pitman JT, Mariani G and Carter EA: Inflammation and infection: Imaging properties of 18F-FDG-labeled white blood cells versus 18F-FDG. J Nucl Med. 46:1522–1530. 2005.PubMed/NCBI
29	Chen DL, Wang X, Yamamoto S, Carpenter D, Engle JT, Li W, Lin X, Kreisel D, Krupnick AS, Huang HJ and Gelman AE: Increased T cell glucose uptake reflects acute rejection in lung grafts. Am J Transplant. 13:2540–2549. 2013. View Article : Google Scholar : PubMed/NCBI